MedPath

Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)

Phase 4
Completed
Conditions
Hypertension
Registration Number
NCT00140959
Lead Sponsor
Organon and Co
Brief Summary

A study to evaluate the effects of combination losartan versus combination atenolol in patients with ambulatory systolic hypertension.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Males or females at least 18 years of age who have ambulatory systolic hypertension.
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Mean daytime ambulatory systolic blood pressure
Secondary Outcome Measures
NameTimeMethod
Ambulatory BP
Pulse pressure
Trough sitting BP
Percentage of patients who reach goal ambulatory systolic BP
© Copyright 2025. All Rights Reserved by MedPath